http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20130142636-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_44f04d319aaa6e66f240244bc905f452 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-245 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-64 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-31 |
filingDate | 2012-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3aa8088dd1f77652a81b78bca98dd187 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f802fb509e0dd2297fc367d62693be67 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad99f4d65b0b8f671fe6ea76d1078bea |
publicationDate | 2013-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-20130142636-A |
titleOfInvention | Method for producing microbial host cell for functional protein production |
abstract | The present invention provides a method for producing a strain library for producing a functional protein, a strain library for producing a functional protein prepared using the library, and a method for producing a functional protein using the library. The library prepared by the method for producing a strain library for producing a functional protein of the present invention provides various DNA translation initiation and / or elongation rates, It is expected to be able to be used for the mass production of various functional proteins using the above-mentioned library, since it is possible not only to solve the problems of inclusion body formation, but also to increase the protein production amount. In particular, Since the functional protein is produced without changing the primary structure, it is expected to be a source technology that can be applied to mass production of biosimilar drugs because it does not cause stability problem due to protein structural change. |
priorityDate | 2012-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 411.